Literature DB >> 22003873

The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation.

Fu L Luan1, Mallika Kommareddi, Diane M Cibrik, Millie Samaniego, Akinlolu O Ojo.   

Abstract

Pancreas after kidney (PAK) transplantation is one of the accepted pancreas transplant modalities. We studied the impact of time interval between kidney and pancreas transplantation on the outcomes of PAK transplantation. Using OPTN/SRTR data, we included 1853 PAK transplants performed between 1996 and 2005 with follow-up until November 1, 2008. Kaplan-Meier survival and multivariate Cox regression analyses were performed using the time interval between kidney and pancreas transplantation either as a categorical (less than one yr, between one and less than three yr, and greater than or equal to three yr) or as a continuous variable (months) to assess kidney graft and patient survival. Patients who received a pancreas transplant three yr or later after kidney transplantation had higher risk of death-censored kidney graft loss (HR 1.56, 95% CI 1.04, 2.32, p = 0.03). Each month beyond three yr between kidney and pancreas transplantation incurred 1% higher risk of subsequent death-censored kidney graft loss (HR 1.01, 95% CI 1.001, 1.02, p = 0.03). In conclusion, time interval between pancreas and kidney transplantation is an independent risk factor of kidney graft loss following pancreas transplantation. Shortening the time interval between pancreas and kidney transplantation to less than three yr may reduce the risk of kidney graft loss in qualified PAK transplant candidates.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22003873      PMCID: PMC3856569          DOI: 10.1111/j.1399-0012.2011.01519.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  19 in total

1.  Pancreas transplantation in type 1 diabetes.

Authors:  Paul Robertson; Connie Davis; Jennifer Larsen; Robert Stratta; David E R Sutherland
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

Review 2.  Data sources and structure.

Authors:  David M Dickinson; Mary D Ellison; Randall L Webb
Journal:  Am J Transplant       Date:  2003       Impact factor: 8.086

3.  Molecular and structural consequences of early renal allograft injury.

Authors:  Keshwar Baboolal; Geraint A Jones; Alenka Janezic; David R Griffiths; Wieslaw A Jurewicz
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

4.  Optimal timing for a pancreas transplant after a successful kidney transplant.

Authors:  A Humar; D E Sutherland; T Ramcharan; R W Gruessner; A C Gruessner; R Kandaswamy
Journal:  Transplantation       Date:  2000-10-27       Impact factor: 4.939

5.  Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation.

Authors:  Herwig-Ulf Meier-Kriesche; Rajendra Baliga; Bruce Kaplan
Journal:  Transplantation       Date:  2003-04-27       Impact factor: 4.939

6.  Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation.

Authors:  Timothy S Larson; Humberto Bohorquez; David J Rea; Scott L Nyberg; Mikel Prieto; Sylvester Sterioff; Stephen C Textor; Thomas R Schwab; Matthew D Griffin; James M Gloor; Yogish C Kudva; Walter K Kremers; Mark D Stegall
Journal:  Transplantation       Date:  2004-03-27       Impact factor: 4.939

7.  Survival after pancreas transplantation in patients with diabetes and preserved kidney function.

Authors:  Jeffrey M Venstrom; Maureen A McBride; Kristina I Rother; Boaz Hirshberg; Trevor J Orchard; David M Harlan
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

8.  The natural history of chronic allograft nephropathy.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

9.  Allograft diabetic nephropathy may progress to end-stage renal disease.

Authors:  Moro O Salifu; Anthony D Nicastri; Mariana S Markell; Halim Ghali; Bruce G Sommer; Eli A Friedman
Journal:  Pediatr Transplant       Date:  2004-08

10.  Natural history, risk factors, and impact of subclinical rejection in kidney transplantation.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.